Glytec announced today that CPS Solutions selected it to serve as an insulin management technology resource.
Waltham, Massachusetts-based Glytec will serve as a resource for CPS’ more than 2,200 pharmacy professionals across more than 800 healthcare facilities nationwide.
Through the collaboration, CPS client facilities can contract for Glytec’s eGlycemic Management System (eGMS) and Glytec’s technical resources to be available to their healthcare professionals.
“For nearly five decades, the CPS team has provided pharmacy departments with access to tools, resources, and services that leverage data to support evidence-based decisions,” CPS SVP of Purchasing and Data Management Len Gray said in a news release. “We’re thrilled to add Glytec’s eGMS to our resource library at a time when its services are most needed. Hospital pharmacy leaders are facing heightened challenges in today’s environment, and glycemic management has rapidly ascended to the top of that list.”
Glytec designed its eGMS system to support patient and provider demands through the Glucommander cloud-based, FDA-cleared software designed to personalize intravenous and subcutaneous insulin dosing support for patients with and without diabetes.
Studies have demonstrated that keeping patients in their target range with Glytec’s eGMS can reduce 30-day readmissions by up to 68% and cut the length of hospital stay by up to 3.2 days.
“CPS has a well-established track record of identifying opportunities for pharmacy improvement and offering the resources and expertise to maximize operational, clinical and financial returns,” said John Downey, chief commercial officer at Glytec. “Our eGMS will augment CPS’ existing resource portfolio and deepen the support services it provides to hospitals and health systems across the country.”
The Centers for Medicare and Medicaid Services (CMS) recently published two new eCQMs to measure glycemic management outcomes designed to address prolonged, untreated high blood sugar and mitigate instances of severe low blood sugar related to insulin management.
Glytec said that poorly managed blood sugar as a result of lack of treatment or treatment with dated protocols represents an issue that its collaboration with CPS aims to tackle.
“As health systems prepare to report on the new CMS hospital harm measures related to glycemic management, it is imperative that pharmacists have the appropriate technology resources to optimize their facility’s insulin dosing,” said Stephanie Ostling Mason, diabetes clinical pharmacist at Glytec. “The pharmacy department is a key stakeholder in insulin protocols, and the collaboration between Glytec and CPS is a significant step towards achieving the industry’s goal of reducing incidences of dysglycemia and making severe hypoglycemia related to insulin a never event.”